Since 2004, the DNDi office in Malaysia has supported a variety of R&D activities across the Asian region, including key preclinical and early clinical studies for the FACT Project, as well as the fostering of the PAN4ND, a regional research platform that focused on the discovery and development of natural substances as therapeutics to neglected diseases. The office is now involved in DNDi’s hepatitis C clinical studies that will take place in the country.


DNDi South-East Asia

L10-7, Menara Sentral Vista,
150, Jln Sultan Abdul Samad
50470 Kuala Lumpur

Tel: +60 3 2716 4159